↓ Skip to main content

Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, June 2003
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
32 Mendeley
Title
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen
Published in
Cancer Chemotherapy and Pharmacology, June 2003
DOI 10.1007/s00280-003-0658-0
Pubmed ID
Authors

Marc Ychou, Jacqueline Duffour, Andrew Kramar, Charles Debrigode, Sophie Gourgou, Françoise Bressolle, Frédéric Pinguet

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 6%
United Kingdom 1 3%
China 1 3%
Unknown 28 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 28%
Other 6 19%
Student > Master 5 16%
Student > Ph. D. Student 2 6%
Professor > Associate Professor 2 6%
Other 5 16%
Unknown 3 9%
Readers by discipline Count As %
Medicine and Dentistry 11 34%
Pharmacology, Toxicology and Pharmaceutical Science 5 16%
Biochemistry, Genetics and Molecular Biology 3 9%
Agricultural and Biological Sciences 3 9%
Nursing and Health Professions 1 3%
Other 6 19%
Unknown 3 9%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2016.
All research outputs
#5,446,994
of 25,374,647 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#272
of 2,561 outputs
Outputs of similar age
#9,517
of 52,567 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#4
of 21 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,561 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 52,567 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.